Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
800,782
-
Shares change
-
-14,735
-
Total reported value, excl. options
-
$40,167,000
-
Value change
-
-$739,161
-
Number of buys
-
3
-
Number of sells
-
-7
-
Price
-
$50.16
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q2 2014
10 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q2 2014.
NOVOZYMES A S DKK 2.0 - COM has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 800,782 shares
.
Largest 10 shareholders include Hemenway Trust Co LLC (150,490 shares), ELEFANTE MICHAEL B (137,070 shares), SOMERVILLE KURT F (115,195 shares), Broderick Brian C (92,356 shares), Kidder Stephen W (89,025 shares), PUZO MICHAEL J (73,680 shares), FIDGEON TIMOTHY F (61,865 shares), Page Arthur B (33,355 shares), Notis-McConarty Edward (32,921 shares), and Fayerweather Charles (14,825 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.